Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse
Authors:
- Divya VohoraDVDivya Vohora
- Malay BhowmikMBMalay Bhowmik
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Systems Neuroscience
- Vol. 6, 26107
Abstract
Histamine H3 receptor antagonists/ inverse agonists possess potential to treat diverse disease states of the central nervous system (CNS). Cognitive dysfunction and motor impairments are the hallmark of multifarious neurodegenerative and/or psychiatric disorders. This review presents the various neurobiological/ neurochemical evidences available so far following H3 receptor inverse agonists/ antagonists in the pathophysiology of Alzheimer’s disease (AD), attention-deficit hyperactivity disorder (ADHD), schizophrenia and drug abuse each of which is accompanied by deficits of some aspects of cognitive and/or motor functions. Whether the H3 receptor inverse agonism modulates the neurochemical basis underlying the disease condition or affects only the cognitive/motor component of the disease process is discussed with the aim to provide a rationale for their use in diverse disease states that are interlinked and are accompanied by some common motor, cognitive and attentional deficits.Keywords
This publication has 98 references indexed in Scilit:
- Cognitive enhancers for the treatment of ADHDPharmacology Biochemistry and Behavior, 2011
- Histamine-dependent behavioral response to methamphetamine in 12-month-old male miceBrain Research, 2011
- Neuroscience of Behavioral and Pharmacological Treatments for AddictionsNeuron, 2011
- Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APPTg2576 mouse model of Alzheimer’s diseaseNeurobiology of Learning and Memory, 2011
- Effects of the H3 antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in ratsPsychopharmacology, 2009
- Altered histamine H3receptor radioligand binding in post‐mortem brain samples from subjects with psychiatric diseasesBritish Journal of Pharmacology, 2009
- Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over‐expressing TASTPM miceBritish Journal of Pharmacology, 2009
- Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal functionNeuropharmacology, 2008
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Is there a common molecular pathway for addiction?Nature Neuroscience, 2005